Skip to main content
. 2015 May 25;6(15):12997–13005. doi: 10.18632/oncotarget.4092

Figure 1. PTPRD mRNA was lower expression in T2D patients.

Figure 1

A. mRNA from 94 T2D patients and 98 normal controls was used for qRT-PCR. Expression levels are expressed relative to controls. B. The 94 patients with T2D were divided into 5 groups according to the disease duration: (1) less than 3 years (N = 19), (2) less than 5 years (N = 16), (3) less than 10 years (N = 27), (4) less than 15 years (N = 17), and (5) longer than 15 years (N = 15). The relative mRNA expression of group (2), (3), (4), and (5) versus to group (1) were 0.64 ± 0.06, 0.71 ± 0.05, 0.40 ± 0.03, and 0.37 ± 0.02, respectively (P < 0.05).